Rethinking TNM: Breast cancer TNM classification for treatment decision-making and research

Breast

Volumn 15, Issue 1, 2006, Pages 3-8

  Veronesi, Umberto ^a   Viale, Giuseppe ^b   Rotmensz, Nicole ^a   Goldhirsch, Aron ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Biological variables; Breast cancer; TNM classification

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BREAST CANCER; CANCER RESEARCH; CANCER SIZE; CANCER STAGING; CARCINOMA IN SITU; CLINICAL FEATURE; DISEASE SEVERITY; EUROPE; GENE OVEREXPRESSION; HUMAN; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE;

EID: 32244442475     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.11.011     Document Type: Review

References (6)

1. L.H. Sobin C. Wittekind TNM classification of malignant tumours 2002 UICC, Wiley-Liss New York
2. F.A. Tavassoli Ductal carcinoma in situ: Introduction of the concept of ductal intraepithelial neoplasia Mod Pathol 11 1998 140-154
3. A. Goldhirsch J.H. Glick R.D. Gelber A.S. Coates H. Senn Meeting highlights: International Consensus Panel on the treatment of primary breast cancer. Seventh international conference on adjuvant therapy of primary breast cancer J Clin Oncol 19 2001 3817-3827
4. M. Bonetti R.D. Gelber A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data Stat Med 19 2000 2595-2609
5. G. Sauter R. Simon Perspective: Predictive molecular pathology N Engl J Med 347 2002 1995-1996
6. M.J. van de Vijver Y.D. He L.J. van 'T Veer et al. A gene expression signature as a predictor of survival in breast cancer N Engl J Med 347 2002 1999-2009